Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Technology Report
  • Published:

China: Lucrative for Pharmaceuticals, Risky for Biotech

Bio/Technology volume 1, pages 172–173 (1983)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Author notes

  1. Myrna Watanabe, Ph.D., is a biologist who has conducted research in China under the auspices of the National Academy of Sciences.

    • Myrna Watanabe
Authors
  1. Myrna Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watanabe, M. China: Lucrative for Pharmaceuticals, Risky for Biotech. Nat Biotechnol 1, 172–173 (1983). https://doi.org/10.1038/nbt0483-172

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0483-172

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing